Cargando…
COVID–19-associated coagulopathy: An exploration of mechanisms
An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to the virus SARS-CoV-2, has infected millions of people and remains a threat to many more. Most critically ill patients have respiratory failure and there is an international effort to understand mechanisms and pred...
Autores principales: | Colling, Meaghan E, Kanthi, Yogendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306998/ https://www.ncbi.nlm.nih.gov/pubmed/32558620 http://dx.doi.org/10.1177/1358863X20932640 |
Ejemplares similares
-
COVID-19 associated coagulopathy: Mechanisms and host-directed treatment
por: Plášek, Jiří, et al.
Publicado: (2022) -
Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021) -
Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021) -
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
por: Knight, Jason S., et al.
Publicado: (2022) -
COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020)